Vara nets first CE mark for autonomous AI breast cancer screening tool

Vara obtains a CE mark for its autonomous triage system as AI becomes increasingly embedded into the cancer screening paradigm. The autonomous triage system’s European market authorisation comes as AI becomes increasingly embedded into the cancer screening paradigm. Vara will now roll out its automated triage system across Europe. Credit: Lina Melnik / Shutterstock.com. Vara has secured a European CE mark for an autonomous, artificial intelligence (AI)-powered breast cancer screening triage tool – marking the first time a device of this nature has secured an authorisation globally. Designated as a Class IIb medical device under the EU’s medical device regulation…

Source: Medical Device Network